Stock page
K2 Capital Acquisition Corp (KTWO)
K2M Group Holdings Inc is a medical device company focused on the development of minimally invasive spine technologies. Its products are used by surgeons to treat a variety of spinal pathologies, include deformities, scoliosis, trauma, and tumors. These products include implants, disposables, and instruments and are largely sold to hospitals. The firm sells products in three categories: complex spine pathologies, minimally invasive procedures, and degenerative and other conditions. Sales of products that treat degenerative and other conditions contribute the largest proportion of revenue. K2M generates the majority of its revenue in the United States.
Quote snapshot
$27.50
Daily change: —
ExchangeNAS
Updated2026-05-09T04:33:43.953466Z
Price chart
Price history
| Name |
|---|
| Revenue |
| Cost Of Goods Sold |
| Gross Profit |
| Gross Margin % |
| Research Development |
| Selling General Admin Expense |
| Depreciation Depletion Amortization |
| Other Operating Expense |
| Total Operating Expense |
| Operating Income |
| Operating Margin |
| Interest Income |
| Interest Expense |
| Other Income Expense |
| Other Income Minority Interest |
| Other Net Income Loss |
| Ebit |
| Ebitda |
| Ebitda Margin |
| Pretax Income |
| Tax Provision |
| Tax Rate |
| Net Income Continuing Operations |
| Net Income Discontinued Operations |
| Net Income |
| Net Income Including Noncontrolling Interests |
| Is Preferred Dividends |
| Shares Outstanding |
| Eps Basic |
| Eps Diluted |
| Net Margin |
SEC filings
Latest 10-K filing table
| Date | Form | Accession | Link |
|---|